Dual heritage
GranBio was founded in Brazil in 2011 by the Gradin family, as part of the Gran Group. In 2019, GranBio acquired AVAPCO, along with its Thomaston, GA refinery
Creating positive, lasting impact
GranBio is biotech company, pioneer in transforming cellulosic biomass into high-value chemical intermediates and biofuels. We were amongst the first to crack the code for cellulosic potential with over 10,000 hours of operation that prove our technology's efficacy in turning a wide range of biomass - including forest, agricultural and sugarcane residues - into biomaterials that help decarbonize hard-to-abate sectors and revitalize rural economies.
Founded in 2011, we create, develop, demonstrate and license state-of-the-art biotechnologies, with an option of EPC (Engineering, Procurement and Construction), in alliance with strategic partners. In addition, we have experience operating integrated biorefineries in Brazil and in the U.S. to produce net-zero products such as advanced ethanol, SAF, nanocellulose and other biochemicals, using sustainably sourced, local biomass.
GranBio was founded in Brazil in 2011 by the Gradin family, as part of the Gran Group. In 2019, GranBio acquired AVAPCO, along with its Thomaston, GA refinery
GranBio has over 400 patents, granted and pending, in the bioeconomy field, with licensing value of $2 billion.
$110MM of federal grants awarded to AVAPCO, a GranBio company, by the U.S. Department of Energy and the U.S. Forest Service demonstrate trust in our technology and business model
Over $500MM investment made over 14 years in cellulosic biofuels, biochemicals and biomaterials.
Our mission is to create positive, lasting impact through innovative cellulosic biotechnologies that help reduce carbon emissions and enable local
communities to prosper. Our vision is to be the world leader in cellulosic biomass innovation. Guided by our values of Integrity, Inclusion, Innovation,
Responsibility and Perseverance, we will be relentless in our work to fulfil our mission and build a legacy we can be proud of.
A journey through time
The first ideas about GranBio’s business plan were born in a cafeteria at Unicamp University in 2011. Unicamp is one of the most innovative institutions in Brazil, with which GranBio regularly collaborates on research and social projects. Since its inception, GranBio had collaboration at its heart, designed to be part of a seamless and prosperous ecosystem.
AVAP Technology proof of concept, GA Tech
GranBio acquires 25% of API Inc.
GranBio acquires 50% of API Inc.
DOE AVAP Award for SAF
GranBio’s IP Valued at $2 billion
Scale-up: 10 plants & 1 billion gallons/year SAF
Integrity is one of our founding values. We are committed to conducting business ethically and in compliance with applicable laws in all countries where we operate. Our Ethics Team and Committee ensure all employees are trained in our Ethics & Compliance policy and guidelines and foster open, transparent dialogue with all stakeholders.
Our drive for innovation is well reflected in our robust Intellectual Property portfolio, with more than 60 patent families and over 400 patents granted and pending. These span the entire process from biomass processing to end-use for biofuels, biochemicals and biomaterials. Our global IP coverage includes the US, Europe (30+ countries), Brazil, Canada, China, India, Malaysia, and others.
250+
150+
Third-party analysis found no FTO concerns for core technologies